RJFSA
SRNE

Raymond James Financial Services Advisors’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Raymond James Financial Services Advisors’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-134,983
Closed -$120K – 3446
2022
Q4 		$120K Sell
134,983
-9,500
-7% -$12.6K ﹤0.01% 2983
2022
Q3 		$227K Buy
144,483
+250
+0.2% +$567 ﹤0.01% 2767
2022
Q2 		$290K Sell
144,233
-16,962
-11% -$29.3K ﹤0.01% 2619
2022
Q1 		$376K Buy
161,195
+12,264
+8% +$38.3K ﹤0.01% 2548
2021
Q4 		$693K Sell
148,931
-66,230
-31% -$411K ﹤0.01% 2181
2021
Q3 		$1.64M Buy
215,161
+24,907
+13% +$211K ﹤0.01% 1615
2021
Q2 		$1.84M Buy
190,254
+10,918
+6% +$86.9K ﹤0.01% 1519
2021
Q1 		$1.48M Buy
179,336
+34,814
+24% +$368K ﹤0.01% 1580
2020
Q4 		$986K Sell
144,522
-93,006
-39% -$747K ﹤0.01% 1714
2020
Q3 		$2.65M Buy
237,528
+180,005
+313% +$1.65M 0.01% 1038
2020
Q2 		$361K Buy
57,523
+44,946
+357% +$172K ﹤0.01% 2131
2020
Q1 		$23K Buy
12,577
+2,050
+19% +$5.91K ﹤0.01% 2364
2019
Q4 		$36K Sell
10,527
-1,932
-16% -$4.61K ﹤0.01% 2780
2019
Q3 		$27K Hold
12,459
– – ﹤0.01% 2733
2019
Q2 		$33K Hold
12,459
– – ﹤0.01% 2766
2019
Q1 		$59K Buy
+12,459
New +$32.7K ﹤0.01% 2694

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $56.9M AUM 80.32% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.04B AUM 17.78% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $470M AUM 15.4% 1-Year Est. Return

Raymond James Financial Services Advisors's SRNE Position: Q1 2023 in Review

Raymond James Financial Services Advisors sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 134,983 shares — an estimated $120K sold.

Raymond James Financial Services Advisors first reported a position in SRNE in Q1 2019 and held it in 16 quarters. The position peaked at $2.65M in Q3 2020. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • Raymond James Financial Services Advisors reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 134,983 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $120K.
  • Raymond James Financial Services Advisors first reported a position in Sorrento Therapeutics, Inc. in Q1 2019 and held it in 16 quarters.
  • Raymond James Financial Services Advisors's Sorrento Therapeutics, Inc. position peaked at $2.65M in Q3 2020.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Raymond James Financial Services Advisors's 13F filing for Q1 2023, filed 14 Apr 2023.